Literature DB >> 15303820

Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in two very-low-birthweight infants.

M M Tatli1, A Kumral, N Duman, K Demir, O Gurcu, H Ozkan.   

Abstract

AIM: To discuss intestinal side effects of ibuprofen in the treatment of patent ductus arteriosus, after having observed two cases of spontaneous intestinal perforation following ibuprofen treatment.
METHODS: Clinical and laboratory records of two preterm infants, who developed intestinal perforation after ibuprofen administration, were evaluated.
RESULTS: Gestational ages of infants were 29 wk (male) and 30 wk (female). Both infants developed intestinal perforations without signs of necrotizing enterocolitis. The perforations cured with Penrose drainage alone.
CONCLUSION: Although ibuprofen is a reasonable treatment alternative to indomethacin, randomized controlled trials, which address potential adverse effects including spontaneous intestinal perforation, are needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303820     DOI: 10.1111/j.1651-2227.2004.tb02702.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

Review 1.  Therapeutic potential to reduce brain injury in growth restricted newborns.

Authors:  Julie A Wixey; Kirat K Chand; Lily Pham; Paul B Colditz; S Tracey Bjorkman
Journal:  J Physiol       Date:  2018-05-23       Impact factor: 5.182

2.  Oral-ibuprofen-induced acute renal failure in a preterm infant.

Authors:  Omer Erdeve; S Umit Sarici; Erkan Sari; Faysal Gok
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

Review 3.  Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus.

Authors:  Mehmet Yekta Oncel; Omer Erdeve
Journal:  World J Clin Pediatr       Date:  2016-02-08

4.  Development of artificial neural networks for early prediction of intestinal perforation in preterm infants.

Authors:  Joonhyuk Son; Daehyun Kim; Jae Yoon Na; Donggoo Jung; Ja-Hye Ahn; Tae Hyun Kim; Hyun-Kyung Park
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

5.  Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.

Authors:  Brian C Gulack; Matthew M Laughon; Reese H Clark; Meera N Sankar; Christoph P Hornik; P Brian Smith
Journal:  Early Hum Dev       Date:  2015-09-19       Impact factor: 2.079

Review 6.  Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis.

Authors:  Souvik Mitra; Ivan D Florez; Maria E Tamayo; Lawrence Mbuagbaw; Thuva Vanniyasingam; Areti Angeliki Veroniki; Adriana M Zea; Yuan Zhang; Behnam Sadeghirad; Lehana Thabane
Journal:  JAMA       Date:  2018-03-27       Impact factor: 56.272

Review 7.  Patent ductus arteriosus in preterm infants: do we have the right answers?

Authors:  Hesham Abdel-Hady; Nehad Nasef; Abd Elazeez Shabaan; Islam Nour
Journal:  Biomed Res Int       Date:  2013-12-23       Impact factor: 3.411

Review 8.  To Feed or Not to Feed: A Critical Overview of Enteral Feeding Management and Gastrointestinal Complications in Preterm Neonates with a Patent Ductus Arteriosus.

Authors:  Silvia Martini; Arianna Aceti; Silvia Galletti; Isadora Beghetti; Giacomo Faldella; Luigi Corvaglia
Journal:  Nutrients       Date:  2019-12-27       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.